Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)
BACKGROUND: The incidence, risk factors, and outcome of stent thrombosis (ST) after percutaneous coronary intervention (PCI) in Middle Eastern patients are largely unknown. OBJECTIVE: To determine the incidence, risk factors and outcome in our population. DESIGN: Retrospective study of a prospective...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
King Faisal Specialist Hospital and Research Centre
2016-01-01
|
Series: | Annals of Saudi Medicine |
Online Access: | https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2016.17 |
_version_ | 1818483143853735936 |
---|---|
author | Akram Saleh Ayman Hammoudeh Ramzi Tabbalat Imadd Al-haddad Eyass Al-Mousa Mohammad Jarrah Mahmoud Izraiq Assem Nammas Husham Janabi Lewa Hazaymeh Ali Shakhatreh Youssef Khadder |
author_facet | Akram Saleh Ayman Hammoudeh Ramzi Tabbalat Imadd Al-haddad Eyass Al-Mousa Mohammad Jarrah Mahmoud Izraiq Assem Nammas Husham Janabi Lewa Hazaymeh Ali Shakhatreh Youssef Khadder |
author_sort | Akram Saleh |
collection | DOAJ |
description | BACKGROUND: The incidence, risk factors, and outcome of stent thrombosis (ST) after percutaneous coronary intervention (PCI) in Middle Eastern patients are largely unknown. OBJECTIVE: To determine the incidence, risk factors and outcome in our population. DESIGN: Retrospective study of a prospective multicenter registry of consecutive patients who underwent PCI between January 2013 and February 2014 (JoPCR1). SETTING: 12 tertiary care centers in Amman and Irbid, Jordan. PATIENTS AND METHODS: We collected clinical baseline and follow-up data. MAIN OUTCOME MEASURES: Incidence of stent thrombosis. RESULTS: The mean (standard deviation) age of patients (n=2426) was 59.0 (10.1) years and 20.6% were women. Stents (n=3038) were drug eluting (89.6%), bare metal (9.4%) or bioabsorbable (1.0%). After 1 year, 47 patients (1.97%) had ST, including 44 (94%) definite and 3 (6%) probable ST. Patients who had ST presented with sudden death (n=6; 12.2%) or with a nonfatal event (n=43; 87.8%). Nonfatal events included non-ST-segment elevation acute coronary syndrome (26; 53%), acute ST segment elevation myocardial infarction (n=15; 31%) or heart failure (n=2; 4.1%). ST was associated with significantly higher one-month (22.0% vs. 0.7%) and one-year (12.3% vs. 0.73%) mortality rates compared with patients who did not have ST (P<;.001). ST patients were younger (mean age 52.9 years vs. 58.4 years), had heart failure (64% vs. 18%), left ventricular ejection fraction (LVEF) <45% (36% vs. 13%), ST-segment deviation (70% vs. 48%), and elevated cardiac biomarkers blood levels (62% vs. 40%). In the multivariate analysis, the only factor that was significantly associated with ST was the heart failure (OR = 3.5, 95% confidence interval: 1.8, 6.6; P<.0001). CONCLUSIONS: The incidence of ST was not different from that in other regions and was associated with an increased one-year mortality. Younger age, heart failure, low LVEF, ST-segment deviation, and elevated blood levels of cardiac biomarkers were predictors of ST. LIMITATIONS: Possible selection bias, recall bias, and missing or incomplete information. The majority of patients were lost to follow up after the 6th month. The registry may not fully represent PCI practice and outcome in all areas in the country or region. |
first_indexed | 2024-12-10T11:56:27Z |
format | Article |
id | doaj.art-90c55459f0644dba81d61e4bb514b369 |
institution | Directory Open Access Journal |
issn | 0256-4947 0975-4466 |
language | English |
last_indexed | 2024-12-10T11:56:27Z |
publishDate | 2016-01-01 |
publisher | King Faisal Specialist Hospital and Research Centre |
record_format | Article |
series | Annals of Saudi Medicine |
spelling | doaj.art-90c55459f0644dba81d61e4bb514b3692022-12-22T01:49:45ZengKing Faisal Specialist Hospital and Research CentreAnnals of Saudi Medicine0256-49470975-44662016-01-01361172210.5144/0256-4947.2016.17asm-1-17Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)Akram Saleh0Ayman Hammoudeh1Ramzi Tabbalat2Imadd Al-haddad3Eyass Al-Mousa4Mohammad Jarrah5Mahmoud Izraiq6Assem Nammas7Husham Janabi8Lewa Hazaymeh9Ali Shakhatreh10Youssef Khadder11From the Cardiology Department, Jordan University Hospital, Amman, JordanFrom the Cardiology Department, Istishari Hospital, Amman, JordanFrom the Cardiology Department, Alkhalidi Hospital, Amman, JordanFrom the Cardiology Department, Jordan Hospital, Amman, JordanFrom the Cardiology Department, Istishari Hospital, Amman, JordanFrom the Cardiology Department, King Abdullah University Hospital, Irbid, JordanFrom the Cardiology Department, Ibn Alyaythem Hospital, Amman, JordanFrom the Cardiology Department, Ibn Alyaythem Hospital, Amman, JordanFrom the Cardiology Department, Prince Hamzeh Hospital, Amman, JordanFrom the Cardiology Department, Jordan University Hospital, Amman, JordanFrom the Cardiology Department, Jordan University Hospital, Amman, JordanFrom the School of Medicine, Jordan University of Science and Technology-Family Medicine, University of Jordan, Irbid, JordanBACKGROUND: The incidence, risk factors, and outcome of stent thrombosis (ST) after percutaneous coronary intervention (PCI) in Middle Eastern patients are largely unknown. OBJECTIVE: To determine the incidence, risk factors and outcome in our population. DESIGN: Retrospective study of a prospective multicenter registry of consecutive patients who underwent PCI between January 2013 and February 2014 (JoPCR1). SETTING: 12 tertiary care centers in Amman and Irbid, Jordan. PATIENTS AND METHODS: We collected clinical baseline and follow-up data. MAIN OUTCOME MEASURES: Incidence of stent thrombosis. RESULTS: The mean (standard deviation) age of patients (n=2426) was 59.0 (10.1) years and 20.6% were women. Stents (n=3038) were drug eluting (89.6%), bare metal (9.4%) or bioabsorbable (1.0%). After 1 year, 47 patients (1.97%) had ST, including 44 (94%) definite and 3 (6%) probable ST. Patients who had ST presented with sudden death (n=6; 12.2%) or with a nonfatal event (n=43; 87.8%). Nonfatal events included non-ST-segment elevation acute coronary syndrome (26; 53%), acute ST segment elevation myocardial infarction (n=15; 31%) or heart failure (n=2; 4.1%). ST was associated with significantly higher one-month (22.0% vs. 0.7%) and one-year (12.3% vs. 0.73%) mortality rates compared with patients who did not have ST (P<;.001). ST patients were younger (mean age 52.9 years vs. 58.4 years), had heart failure (64% vs. 18%), left ventricular ejection fraction (LVEF) <45% (36% vs. 13%), ST-segment deviation (70% vs. 48%), and elevated cardiac biomarkers blood levels (62% vs. 40%). In the multivariate analysis, the only factor that was significantly associated with ST was the heart failure (OR = 3.5, 95% confidence interval: 1.8, 6.6; P<.0001). CONCLUSIONS: The incidence of ST was not different from that in other regions and was associated with an increased one-year mortality. Younger age, heart failure, low LVEF, ST-segment deviation, and elevated blood levels of cardiac biomarkers were predictors of ST. LIMITATIONS: Possible selection bias, recall bias, and missing or incomplete information. The majority of patients were lost to follow up after the 6th month. The registry may not fully represent PCI practice and outcome in all areas in the country or region.https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2016.17 |
spellingShingle | Akram Saleh Ayman Hammoudeh Ramzi Tabbalat Imadd Al-haddad Eyass Al-Mousa Mohammad Jarrah Mahmoud Izraiq Assem Nammas Husham Janabi Lewa Hazaymeh Ali Shakhatreh Youssef Khadder Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1) Annals of Saudi Medicine |
title | Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1) |
title_full | Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1) |
title_fullStr | Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1) |
title_full_unstemmed | Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1) |
title_short | Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1) |
title_sort | incidence and prognosis of stent thrombosis following percutaneous coronary intervention in middle eastern patients the first jordanian percutaneous coronary intervention registry jopcr1 |
url | https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2016.17 |
work_keys_str_mv | AT akramsaleh incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 AT aymanhammoudeh incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 AT ramzitabbalat incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 AT imaddalhaddad incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 AT eyassalmousa incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 AT mohammadjarrah incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 AT mahmoudizraiq incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 AT assemnammas incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 AT hushamjanabi incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 AT lewahazaymeh incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 AT alishakhatreh incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 AT youssefkhadder incidenceandprognosisofstentthrombosisfollowingpercutaneouscoronaryinterventioninmiddleeasternpatientsthefirstjordanianpercutaneouscoronaryinterventionregistryjopcr1 |